• 2-Hydroxypropyl-β-cyclodextrin: Technical Guide for Solubili

  2026-05-14

  2-Hydroxypropyl-β-cyclodextrin addresses the challenge of solubilizing poorly water-soluble, hydrophobic research compounds—especially those containing aromatic or phenyl groups—by forming inclusion complexes. Its use is validated for drug formulation excipient and pharmaceutical solubility improvement workflows; broader applications are not supported by current product documentation.

• RNA Clean and Concentrator Kit: Precision RNA Purification S

  2026-05-13

  The RNA Clean and Concentrator Kit streamlines high-yield RNA purification from enzymatic reactions, delivering exceptional purity and recovery for demanding molecular biology workflows. Its robust spin column technology ensures reproducibility and speed, empowering researchers to confidently pursue complex studies such as mitophagy modulation in NAFLD models.

• Bradykinin (SKU BA5201): Practical Guide for Vascular Resear

  2026-05-13

  Bradykinin (SKU BA5201) addresses the need for a reliable, well-characterized endothelium-dependent vasodilator in protocols probing vascular permeability, smooth muscle contraction, and inflammation signaling. This product is best suited for controlled laboratory studies requiring reproducible modulation of vascular and inflammatory responses; it should not be used for diagnostic or therapeutic purposes.

• Atorvastatin: HMG-CoA Reductase Inhibitor in Bench Research

  2026-05-12

  Atorvastatin, a leading HMG-CoA reductase inhibitor from APExBIO, empowers advanced cholesterol metabolism and oncology research with precise, reproducible control over cellular pathways. This article details experimental protocols, troubleshooting guidance, and the latest in ferroptosis-driven cancer applications, anchored by recent peer-reviewed evidence.

• Angiotensin II: Mechanistic Insights for Translational Vascu

  2026-05-12

  This article provides advanced guidance for translational researchers leveraging Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) in hypertension mechanism study, vascular smooth muscle cell hypertrophy research, and cardiovascular remodeling investigation. Bridging molecular signaling, validated protocols, and recent cross-domain findings, it positions APExBIO’s Angiotensin II as a gold-standard reagent while highlighting practical workflow integration and emerging scientific frontiers.

• Targeting BCL-XL and MCL-1 in Glioblastoma with BH3-Mimetics

  2026-05-11

  The reference study highlights that glioblastoma (GBM) cells exhibit increased expression of anti-apoptotic proteins BCL-XL and MCL-1, rendering them highly susceptible to BH3-mimetic inhibitors. Sequential inhibition of these proteins in patient-derived GBM stem-like cells induces marked tumor regression in preclinical models, offering a targeted approach to overcoming resistance in this aggressive cancer.

• Amikacin Sulfate: Optimizing Targeted Delivery in Mycobacter

  2026-05-11

  Amikacin Sulfate empowers researchers to achieve efficient, targeted antibiotic delivery with high intracellular uptake and minimized toxicity. This guide translates bench protocols and troubleshooting strategies into actionable workflows, leveraging APExBIO’s validated product for reproducible, high-impact results in non-tuberculous mycobacterial infection models.

• Superoxide Dismutase (SOD) Activity Assay Kit: Technical Use

  2026-05-10

  The Superoxide Dismutase (SOD) Activity Assay Kit provides a rapid, quantitative approach for measuring SOD enzyme activity in biological fluids, supporting research on oxidative stress and antioxidative defenses. This kit is not intended for diagnostic or medical applications and should be used exclusively for scientific research requiring robust, colorimetric SOD measurement.

• Clozapine N-oxide: Precision Chemogenetics for Neuronal Modu

  2026-05-09

  Clozapine N-oxide (CNO) is the gold standard for precise, non-invasive chemogenetic modulation of neuronal circuits using DREADDs. This article dissects its applied use-cases, protocol optimizations, and troubleshooting in advanced GPCR signaling and neuroscience research, with actionable insights from recent studies.

• L-Glutathione Reduced in Cancer Metabolism: Beyond Redox Con

  2026-05-09

  Explore how L-Glutathione Reduced advances cancer metabolism research as both a redox modulator and metabolic probe. This article uncovers mechanistic insights and assay decisions that differentiate it from typical antioxidant applications.

• Resveratrol’s Hormetic Rescue of Radiation-Induced Endotheli

  2026-05-08

  This study establishes a robust in vitro endothelial model to systematically evaluate radiation-induced vascular injuries and demonstrates the dose-dependent, hormetic rescue effect of resveratrol on DNA integrity and tube formation. The findings optimize screening protocols for radioprotective compounds and provide a powerful platform for mechanistic and translational research in vascular protection.

• Optimizing Cationic LNPs for Enhanced mRNA Vaccine Delivery

  2026-05-07

  This study systematically evaluates the impact of cationic lipid enrichment—specifically DOTAP and DODAP—on ALC-0315-based lipid nanoparticles (LNPs) for mRNA vaccine delivery. The findings highlight how fine-tuning LNP composition can localize mRNA expression and modulate immune responses, with practical implications for next-generation vaccine design.

• Peptidisc-Driven Clustering: Enabling Multimeric Nanobody As

  2026-05-07

  Chen and Duong van Hoa introduce a peptidisc-assisted method to cluster nanobodies into stable, multimeric, and multispecific assemblies, leveraging hydrophobic forces for enhanced affinity and functional versatility. This innovation expands the protein engineering toolbox and has broad implications for affinity-based assays and next-generation protein therapeutics.

• GSK-923295 and the Next Frontier in Centromere-Targeted Onco

  2026-05-06

  This thought-leadership article explores the mechanistic rationale and translational opportunity for targeting the centromere-mitosis axis in cancer research. It bridges emerging insights into CTCF’s role in centromere integrity with the strategic deployment of GSK-923295, a potent CENP-E inhibitor from APExBIO, highlighting actionable protocol parameters and translational implications for researchers aiming to manipulate chromosome alignment and mitotic fidelity in preclinical models.

• Refining In Vitro Drug Response Evaluation in Cancer Researc

  2026-05-06

  Schwartz’s dissertation advances in vitro anti-cancer drug response evaluation by distinguishing between proliferative arrest and cell death, clarifying their unique contributions to drug efficacy. This framework enables more precise interpretation of preclinical data and informs improved assay and model selection for cancer biology research.

448 records 18/30 page Previous Next First page 上5页 1617181920 下5页 Last page